Related Experiment Video
Updated: Aug 26, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Urinary immunocytology for primary bladder B cell lymphoma
Michael Froehner1, Michael Haase, Oliver W Hakenberg
1Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany.
Insights
Urinary immunocytology effectively diagnosed bladder lymphoma by identifying CD20-positive cells. This method aids in differentiating lymphoma from inflammation in patients with pyuria.
Area of Science:
- Uropathology
- Oncology
- Immunocytochemistry
Background:
- Primary high-grade, large-cell, B-cell lymphoma of the bladder is a rare malignancy.
- Diagnosis can be challenging, often requiring invasive procedures.
- Distinguishing lymphoma from inflammatory conditions in the bladder is critical for appropriate treatment.
Observation:
- A case study involving a patient with primary bladder lymphoma.
- Urinary samples were analyzed using immunocytology.
- Abundant leukocytes were present alongside lymphoma cells in the urine.
Findings:
- Immunocytologic staining for CD20 successfully differentiated lymphoma cells from leukocytes.
- CD20 is a specific B-cell marker, confirming the B-cell origin of the lymphoma.
- Urinary immunocytology proved to be a valuable diagnostic tool in this case.
Implications:
- Urinary immunocytology offers a less invasive method for diagnosing bladder lymphoma.
- This technique can aid in the differential diagnosis of chronic bladder inflammation with pyuria.
- Further research may establish immunocytology as a standard diagnostic approach for suspected bladder malignancies.
Abstract:
Urinary immunocytology is described as a diagnostic tool in a patient with a primary high-grade, large-cell, B cell lymphoma of the bladder. Lymphoma cells were distinguished from abundant leukocytes by immunocytologic staining for CD20. This technique might be useful in the differential diagnosis of patients with chronic bladder inflammation accompanied by pyuria.
More Related Videos
09:243-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
Published on: September 13, 2018
06:12Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
Published on: May 29, 2015